Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Depreciation & Amortization (CF): 2013-2024

Historic Depreciation & Amortization (CF) for Armata Pharmaceuticals (ARMP) over the last 12 years, with Dec 2024 value amounting to $1.3 million.

  • Armata Pharmaceuticals' Depreciation & Amortization (CF) rose 196.59% to $261,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $1.1 million, marking a year-over-year increase of 216.91%. This contributed to the annual value of $1.3 million for FY2024, which is 36.32% up from last year.
  • As of FY2024, Armata Pharmaceuticals' Depreciation & Amortization (CF) stood at $1.3 million, which was up 36.32% from $972,000 recorded in FY2023.
  • Over the past 5 years, Armata Pharmaceuticals' Depreciation & Amortization (CF) peaked at $1.3 million during FY2024, and registered a low of $892,000 during FY2022.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $972,000 (2023), whereas its average is $1.1 million.
  • As far as peak fluctuations go, Armata Pharmaceuticals' Depreciation & Amortization (CF) declined by 25.67% in 2022, and later surged by 36.32% in 2024.
  • Yearly analysis of 5 years shows Armata Pharmaceuticals' Depreciation & Amortization (CF) stood at $1.1 million in 2020, then rose by 7.72% to $1.2 million in 2021, then declined by 25.67% to $892,000 in 2022, then increased by 8.97% to $972,000 in 2023, then spiked by 36.32% to $1.3 million in 2024.